New gout drug under investigation has dual benefit

The novel uricosuric drug arhalofenate significantly reduced the incidence of gout flares, compared with allopurinol alone and placebo, and also modestly lowered serum urate levels in a phase IIb...
Source: Rheumatology News - Category: Rheumatology Source Type: research